{"disease":{"id":"metastases","name":"metastases"},"drugs":{"marketed":[{"drug_id":"lorlatinib-with-chemotherapy-2","indication_name":"ALK-positive metastatic NSCLC with brain metastases and with or without echinoderm microtubule-associated protein-like 4 (EML4) anaplastic lymphoma kinase (ALK) fusion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lorlatinib with chemotherapy 2","generic_name":"lorlatinib-with-chemotherapy-2","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"ALK","drug_class":"ALK inhibitor","quality_score":40,"revenue":"798","mechanism":""},{"drug_id":"lorlatinib-with-chemotherapy-2","indication_name":"Anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) with brain metastases","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lorlatinib with chemotherapy 2","generic_name":"lorlatinib-with-chemotherapy-2","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"ALK","drug_class":"ALK inhibitor","quality_score":40,"revenue":"798","mechanism":""},{"drug_id":"lorlatinib-with-chemotherapy-2","indication_name":"ALK-positive metastatic NSCLC without brain metastases","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lorlatinib with chemotherapy 2","generic_name":"lorlatinib-with-chemotherapy-2","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"ALK","drug_class":"ALK inhibitor","quality_score":40,"revenue":"798","mechanism":""},{"drug_id":"radium-223","indication_name":"Castration-Resistant Prostate Cancer, Bone Metastases","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Radium-223","generic_name":"radium-223","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Bone cells","drug_class":"Radiopharmaceutical","quality_score":50,"revenue":"400","mechanism":""},{"drug_id":"zometa","indication_name":"Bone Metastases of Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zometa","company_name":"University of Arkansas","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zoledronic-acid","indication_name":"Bone Metastases from Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zometa","generic_name":"ZOLEDRONIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"zoledronic acid","quality_score":80,"revenue":null,"mechanism":"Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity."},{"drug_id":"zoledronate","indication_name":"Bone Metastases of Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zoledronate","company_name":"Children's Hospital Medical Center, Cincinnati","drug_phase":"marketed","molecular_target":"Butyrophilin subfamily 3 member A1, 72 kDa type IV collagenase, Geranylgeranyl pyrophosphate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pamidronate","indication_name":"Osteolytic Bone Metastases of Breast Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pamidronate","company_name":"US Department of Veterans Affairs","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase, Farnesyl pyrophosphate synthase, Hypoxanthine-guanine phosphoribosyltransferase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"pamidronic-acid","indication_name":"Osteolytic Bone Metastases of Breast Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aredia","generic_name":"PAMIDRONIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"Bisphosphonate","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"zoledronic-acid","indication_name":"Bone Metastases of Solid Tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zometa","generic_name":"ZOLEDRONIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Farnesyl pyrophosphate synthase","drug_class":"zoledronic acid","quality_score":80,"revenue":null,"mechanism":"Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity."}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07446946","title":"Surgical Management of Pancreatic Cancer With Liver Metastasis (Oligometastasis)","phase":"","overall_status":"COMPLETED","enrollment_count":68303,"lead_sponsor_name":"Richard Hunger","has_results":false},{"nct_id":"NCT06106568","title":"An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":39624,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04654975","title":"Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT05475054","title":"Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes","phase":"","overall_status":"COMPLETED","enrollment_count":9963,"lead_sponsor_name":"Fondazione Poliambulanza Istituto Ospedaliero","has_results":false},{"nct_id":"NCT04075305","title":"The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT03222895","title":"Distribution of Lymph Node Metastases in Esophageal Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT06544668","title":"A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07225491","title":"Spine Oncology Registry","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03346655","title":"Brain Metastases in Norway - A Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT06335251","title":"Radiotherapy Treatments for Neoplasms of the Limbs","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT07198256","title":"AI-assisted Diagnosis of Malignant Brain Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03244020","title":"LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2868,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05816902","title":"AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":2779,"lead_sponsor_name":"Peking Union Medical College","has_results":false},{"nct_id":"NCT04947020","title":"DataBase for Analysis of Rectal Cancer Oncological Results","phase":"","overall_status":"COMPLETED","enrollment_count":2443,"lead_sponsor_name":"Jagiellonian University","has_results":false},{"nct_id":"NCT03977818","title":"Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa","phase":"","overall_status":"COMPLETED","enrollment_count":2165,"lead_sponsor_name":"Institut Bergonié","has_results":true},{"nct_id":"NCT00321464","title":"A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2049,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05910112","title":"Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05616377","title":"Combination of Local Therapy and Target Therapy for Brain Metastases With EGFR Mutation","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05609162","title":"Treatments for Brain Metastases With Poor Prognostic Factors","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT00321620","title":"Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1904,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00330759","title":"Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1779,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01345019","title":"Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1718,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07399236","title":"AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07380464","title":"A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Cai Zerong","has_results":false},{"nct_id":"NCT06179602","title":"Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT03924609","title":"Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06555354","title":"MicroRNAs and Prognosis in Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1432,"lead_sponsor_name":"Casa Sollievo della Sofferenza IRCCS","has_results":false},{"nct_id":"NCT02051218","title":"Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1380,"lead_sponsor_name":"Swiss Cancer Institute","has_results":false},{"nct_id":"NCT06221072","title":"A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1360,"lead_sponsor_name":"Shanghai JMT-Bio Inc.","has_results":false},{"nct_id":"NCT06493448","title":"Prospective Observational Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1326,"lead_sponsor_name":"Lin Chen","has_results":false},{"nct_id":"NCT00242723","title":"Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining","phase":"","overall_status":"RECRUITING","enrollment_count":1310,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04170777","title":"Perfexion Registration Using CBCT","phase":"","overall_status":"COMPLETED","enrollment_count":1250,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06356779","title":"Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Gitte Fredberg Persson MD PhD","has_results":false},{"nct_id":"NCT06153576","title":"The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures","phase":"","overall_status":"COMPLETED","enrollment_count":1120,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03216551","title":"Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)","phase":"","overall_status":"COMPLETED","enrollment_count":1076,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07180641","title":"National Registry of Hepatic Metastases From Non-Colorectal Cancer\"","phase":"","overall_status":"COMPLETED","enrollment_count":1039,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT00097487","title":"A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT03689439","title":"Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006)","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05375591","title":"AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false},{"nct_id":"NCT05267158","title":"The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT06149884","title":"Micrometastases in Axillary Lymph Nodes in Breast Cancer, Post-neoadjuvant Chemotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":978,"lead_sponsor_name":"Gangnam Severance Hospital","has_results":false},{"nct_id":"NCT05270707","title":"HyperArc Registry Study","phase":"","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Varian, a Siemens Healthineers Company","has_results":false},{"nct_id":"NCT03398915","title":"The European Robotic Spinal Instrumentation (EUROSPIN) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":932,"lead_sponsor_name":"Marc Schröder","has_results":true},{"nct_id":"NCT00699751","title":"A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":921,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06713941","title":"Management of Bone Metastases","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":900,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04859569","title":"Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":850,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT05464992","title":"Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Centre Paul Strauss","has_results":false},{"nct_id":"NCT06367491","title":"National Database of Bone Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","has_results":false},{"nct_id":"NCT01231347","title":"QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"NantCell, Inc.","has_results":true},{"nct_id":"NCT06093022","title":"Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}